June and Sadelain’s “complementary studies” on CAR-T cells on the path from basic research to clinical application have driven the development of “therapeutics for the treatment of patients with blood ...
“Increasing virtual communication and treatment options offers multiple benefits for clinical trials, as one third of all patients in trials reported that even before COVID-19, they had difficulty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results